Rezultati pretraživanja
  1. 23. stu 2019.

    There is large practice variation among institutions regarding & antithrombin supplementation during Based on 273 responses UF heparin is used in 96.6% of centers, with pTT monitoring in 41.8%, ACT in 30.0%, and anti-factor Xa activity in 22.7% of centers

    Prikaži ovu nit
  2. 24. srp 2019.

    Excited to share my first study published today in on recurrence risk after stopping for unprovoked . Big thanks to the MARVELOUS collaborators, for funding/support & for continued mentorship

    Prikaži ovu nit
  3. 16. lis 2019.

    Patient 1 randomized in the Danish Warfarin-Dialysis study!

  4. 13. velj 2019.

    How best to care for patients with at risk of or requiring ? All is revealed in an Grand Round from the team :

  5. Watchman versus Amplatzer for left atrial appendage occlusion. Learn more about safety and efficacy of these two devices:

  6. 4. velj
  7. 4. velj
  8. 4. velj

    Atrial Fibrillation and Cognitive Function JACC Review Topic of the Week

  9. 3. velj
    Odgovor korisnicima i sljedećem broju korisnika:

    I would only do systematic in group 4 PH ( & ). Please note that some of the definitions in this article are outdated now. New PH definition = mPAP >20 mmHg + PVR >3 WU (as opposed to 25 mmHg cut-off before)

  10. 3. velj

    In January's issue of .. in , How to optimise for patients who are , warning syndromes & much more . Access is via NHS , with any❓

  11. 3. velj

    In patients with , the risk for death during was about one third lower in morbidly patients than in those with normal weight, independently of the presence of .

    Prikaži ovu nit
  12. 2. velj

    🩸CHA2DS2-VASc score for in Congestive heart failure = 1 point Hypertension = 1 point Age >75 = 2 points Diabetes = 1 point Stroke or TIA = 2 points Vascular disease = 1 point Age 65-74 = 1 point Sex (female) = 1 point

  13. 1. velj

    Thanks for sharing. Post stroke poses different challenges given the other medical conditions, interactions with etc.

  14. 31. sij

    Ready for my Atrial Fibrillation Clinic, with various decision aids to help patients make informed decisions about anticoagulation treatment

  15. 31. sij

    People living with and those who require therapy both benefit from which allow them to monitor their health

  16. 30. sij

    Question to my friends on Twitter. What is the upper limit of weight for use of or other in an obese patient with Embolism?

  17. 30. sij

    The latest Newsletter is available now. If you are not already subscribed vist:

  18. 29. sij

    A really simple project emedding NICE evidence based practice for safe poor TTR is worse than no warfarin therapy at all. Pharmacist led reviews switched eligible patients to DOAC or improved patient compliance with warfarin. Real

  19. 22. sij

    Comparing outcomes following the perioperative interruptions of DOACs and VKAs among patients with atrial fibrillation. VKAs associated with increased major bleeding post-operatively.

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.